Mural Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	58	99	-	-
Enterprise Value	-162	-157	19	25
PE Ratio	-	-0.48	-	-
PB Ratio	0.25	0.38	-	-
P/FCF Ratio	-	-0.50	-	-
P/OCF Ratio	-	-0.51	-	-
EV/EBITDA Ratio	-	0.82	-0.11	-0.15
EV/EBIT Ratio	-	0.81	-0.10	-0.14
EV/FCF Ratio	-	0.80	-0.11	-0.16
Debt / Equity Ratio	0.06	0.06	-0.90	-1.42
Debt / EBITDA Ratio	-	-0.08	-0.11	-0.15
Debt / FCF Ratio	-	-0.08	-0.11	-0.16
Quick Ratio	11.00	9.34	0	0
Current Ratio	11.27	9.56	0.12	0.13
Return on Equity (ROE)	-	-171.30%	960.20%	-
Return on Assets (ROA)	-	-123.70%	-551.30%	-
Return on Capital (ROIC)	-	-70.38%	8146.39%	-2361.18%
Earnings Yield	-209.96%	-	-
FCF Yield	-200.10%	-	-
Buyback Yield / Dilution	-0.62%	-	-	-
Total Shareholder Return	-0.62%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).